| Titolo | Pubblicato in | Anno |
|---|---|---|
| Stage IV gastro-entero-pancreatic neuroendocrine neoplasms. A risk score to predict clinical outcome | THE ONCOLOGIST | 2017 |
| Everolimus in pancreatic neuroendocrine carcinomas G3 | PANCREAS | 2017 |
| Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors. a systematic review and meta-analysis | ONCOTARGET | 2017 |
| A case of pancreatic small cell neuroendocrine carcinoma associated with SIADH | PANCREAS | 2016 |
| Digestive neuroendocrine neoplasms. A 2016 overview | DIGESTIVE AND LIVER DISEASE | 2016 |
| Controversies in the treatment of digestive neuroendocrine tumors | JOURNAL OF CANCER METASTASIS AND TREATMENT | 2016 |
| Risk and protective factors for small intestine neuroendocrine tumors: a prospective case-control study | NEUROENDOCRINOLOGY | 2016 |
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma
